Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.
about
Silica-based matrices: State of the art and new perspectives for therapeutic drug delivery.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Multiple emulsions as effective platforms for controlled anti-cancer drug delivery.Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.Antioxidant activity of idebenone-loaded neutral and cationic solid-lipid nanoparticles.Chitosan microencapsulation of the dispersed phase of an O/W nanoemulsion to hydrochlorothiazide delivery.Nanomicelle-Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo.Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies.Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
P2860
Q38282549-8E727A81-72C3-48F1-AA40-4BA17AD6A416Q38648168-0CDB700B-CA97-44E2-9502-31C4AB799ADBQ38694627-88BAD2ED-EFA1-4046-A42D-CA794D57FE62Q38714705-CE638D2A-4DEE-41B6-9DD8-0FE9A9FEDC81Q40653236-9A670C0B-FFDA-4553-89CD-E2057A6FC307Q46897674-FA1AAE49-E183-4C66-B7ED-CD0094D72AE9Q48055204-2CE51BDB-4A58-4031-AF74-86A600C2992DQ48154366-D75401ED-6C80-4C12-A7DB-5E9260EB65DAQ53486844-89F8AE9A-9B37-4A07-A9EC-FBFFBC340C5AQ55039354-53B810DE-7CBD-4511-9016-ABD13941A612
P2860
Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Design of cationic lipid nanop ...... acterization and cytotoxicity.
@en
Design of cationic lipid nanop ...... acterization and cytotoxicity.
@nl
type
label
Design of cationic lipid nanop ...... acterization and cytotoxicity.
@en
Design of cationic lipid nanop ...... acterization and cytotoxicity.
@nl
prefLabel
Design of cationic lipid nanop ...... acterization and cytotoxicity.
@en
Design of cationic lipid nanop ...... acterization and cytotoxicity.
@nl
P2093
P50
P1476
Design of cationic lipid nanop ...... acterization and cytotoxicity.
@en
P2093
Eliana B Souto
Maria A Egea
Maria L Garcia
Selma B Souto
P356
10.1016/J.IJPHARM.2013.11.025
P407
P577
2013-11-23T00:00:00Z